{"brief_title": "Dehydroepiandrosterone Effects on HIV-1 Replication", "brief_summary": "This study's purpose is to learn how dehydroepiandrosterone (DHEA) affects the HIV virus, the immune system, hormone levels, body composition and quality of life.", "condition": ["HIV Infections"], "intervention_type": ["Drug"], "intervention_name": ["DHEA"], "criteria": "Inclusion criteria: - Evidence of HIV-1 infection - HIV RNA <50 copies/mL - Stable antiretroviral treatment regimen for at least 8 weeks - Age 18 years or older - Normal pap smear and mammograph within 1 year (females) - Normal prostate-specific antigen level with in one year, age adjusted (males) Exclusion criteria: - Active opportunistic infections or malignancy other than localized cutaneous KS lesions - Concurrent or prior use within the past 8 weeks of DHA, testosterone, other anabolic steroids, corticosteroids, megestrol acetate, growth hormone, IL-2, or thalidomide - Diagnosis of AIDS Dementia Complex (stage II or higher) - Active substance abuse (e.g., alcohol or injection drugs) - Evidence of severe liver dysfunction or hepatic transaminases greater than 3x the upper normal limit - Pregnant or breast-feeding - History of endocrinologically-responsive tumors (e.g., breast, ovarian, uterine, or prostatic cancer, or malignant melanoma)", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "quality of life", "mesh_term": ["HIV Infections", "Dehydroepiandrosterone"], "id": "NCT00065104"}